4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001671311-25-000009
Chief Operating Officer sold 21,208 shares at an average $22.01 ($466,870)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jarrett Jennifer · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-16 | Sale : show line 1 in the form 10b5-1 | −11,225 | $21.88 | $245,651 | 203,007 | D |
| 2025-12-17 | Sale : show line 2 in the form 10b5-1 | −9,983 | $22.16 | $221,218 | 193,024 | D |
| Open-market sales · 21,208 sh · avg $22.01 · $466,870 | ||||||
Loading xslF345X05/wk-form4_1766097311.xml…